フォロー
Steven F Baker
Steven F Baker
Assistant Professor, Lovelace Biomedical Research Institute
確認したメール アドレス: lovelacebiomedical.org - ホームページ
タイトル
引用先
引用先
Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development
A Nogales, SF Baker, E Ortiz-Riaño, S Dewhurst, DJ Topham, ...
Journal of virology 88 (18), 10525-10540, 2014
1522014
The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?
S Ramon, SF Baker, JM Sahler, N Kim, EA Feldsott, CN Serhan, ...
The Journal of immunology 193 (12), 6031-6040, 2014
1282014
Influenza A and B virus intertypic reassortment through compatible viral packaging signals
SF Baker, A Nogales, C Finch, KM Tuffy, W Domm, DR Perez, DJ Topham, ...
Journal of virology 88 (18), 10778-10791, 2014
992014
Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors
JD Bauman, D Patel, SF Baker, RSK Vijayan, A Xiang, AK Parhi, ...
ACS chemical biology 8 (11), 2501-2508, 2013
942013
Replication-competent influenza A viruses expressing reporter genes
M Breen, A Nogales, SF Baker, L Martínez-Sobrido
Viruses 8 (7), 179, 2016
822016
Replication-competent influenza A viruses expressing a red fluorescent protein
A Nogales, SF Baker, L Martínez-Sobrido
Virology 476, 206-216, 2015
792015
Protection against lethal influenza with a viral mimic
SF Baker, H Guo, RA Albrecht, A García-Sastre, DJ Topham, ...
Journal of virology 87 (15), 8591-8605, 2013
722013
Differential splicing of ANP32A in birds alters its ability to stimulate RNA synthesis by restricted influenza polymerase
SF Baker, MP Ledwith, A Mehle
Cell reports 24 (10), 2581-2588. e4, 2018
662018
Influenza virus recruits host protein kinase C to control assembly and activity of its replication machinery
A Mondal, AR Dawson, GK Potts, EC Freiberger, SF Baker, LA Moser, ...
Elife 6, e26910, 2017
652017
High-affinity H7 head and stalk domain–specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine
JL Halliley, S Khurana, F Krammer, T Fitzgerald, EM Coyle, KY Chung, ...
The Journal of infectious diseases 212 (8), 1270-1278, 2015
452015
Development and applications of single-cycle infectious influenza A virus (sciIAV)
A Nogales, SF Baker, W Domm, L Martínez-Sobrido
Virus research 216, 26-40, 2016
432016
Development of a Mouse-Adapted Live Attenuated Influenza Virus That Permits In Vivo Analysis of Enhancements to the Safety of Live Attenuated Influenza Virus …
A Cox, SF Baker, A Nogales, L Martínez-Sobrido, S Dewhurst
Journal of Virology 89 (6), 3421-3426, 2015
412015
Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines
SF Baker, A Nogales, L Martínez-Sobrido
Future virology 10 (6), 715-730, 2015
372015
Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies
M Breen, A Nogales, SF Baker, DR Perez, L Martinez-Sobrido
PLoS One 11 (1), e0147723, 2016
352016
Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus
H Guo, SF Baker, L Martínez-Sobrido, DJ Topham
Journal of virology 88 (20), 12006-12016, 2014
352014
Mutations designed by ensemble defect to misfold conserved RNA structures of influenza A segments 7 and 8 affect splicing and attenuate viral replication in cell culture
T Jiang, A Nogales, SF Baker, L Martinez-Sobrido, DH Turner
PloS one 11 (6), e0156906, 2016
302016
Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010–2011 trivalent inactivated influenza vaccination in healthcare personnel
MR Laguio-Vila, MG Thompson, S Reynolds, SM Spencer, M Gaglani, ...
Open Forum Infectious Diseases 2 (1), ofu115, 2015
282015
EPS8 facilitates uncoating of influenza A virus
GP Larson, V Tran, S Yú, Y Caì, CA Higgins, DM Smith, SF Baker, ...
Cell reports 29 (8), 2175-2183. e4, 2019
262019
Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA)
SF Baker, A Nogales, FW Santiago, DJ Topham, L Martínez-Sobrido
Vaccine 33 (30), 3562-3570, 2015
242015
ANP32B, or not to be, that is the question for influenza virus
SF Baker, A Mehle
Elife 8, e48084, 2019
112019
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20